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Role of distinct type IV collagen networks in glomerular develop-
ment and function.
Background. In X-linked Alport syndrome, mutations in the
COL4A5 gene encoding the a5 chain of type IV collagen result in
progressive renal failure. This nephropathy appears to relate to
the arrest of a switch from an a1/a2 to an a3/a4/a5 network of
type IV collagen in the developing glomerular basement mem-
brane (GBM; Kalluri et al, J Clin Invest 99:2470, 1997).
Methods. We examined the role of this switch in glomerular
development and function using a canine model of X-linked
nephritis with a COL4A5 mutation. The electron microscopic
appearance and the expression of the a1-a6 chains of type IV
collagen in the GBM was correlated with glomerular function.
Results. In normal neonatal glomeruli, once capillary loops were
present, there was staining of GBM for the a1-a5 chains. Prior to
this stage, only a1 and a2 chains were present, with rare glomeruli
positive for the a5 chain. As glomeruli matured, the a1 and a2
chains tended to disappear from the GBM, with the a3-a5 chains
remaining. In affected male dogs, only the a1 and a2 chains were
detected at any stage. GBM ultrastructure in these dogs remained
normal until one month and proteinuria did not appear until two
months.
Conclusion. Our results show that normal glomerular develop-
ment involves a switch in type IV collagen networks. In affected
male dogs, a failure of this switch results in an absence of the
a3/a4/a5 network and a persistence of the a1/a2 network in
GBM. GBM ultrastructure and glomerular function remain nor-
mal for one month, indicating that GBM deterioration in Alport
syndrome begins as a postnatal process. Hence, only the a1/a2
network is essential for normal glomerular development, whereas
the a3/a4/a5 network is essential for long-term maintenance of
glomerular structure and function.
Alport syndrome is a hereditary disorder characterized
by progressive nephropathy that is frequently associated
with sensorineural deafness and ocular abnormalities [1–4].
About 80% of affected families show X-linked inheritance,
and the remainder are autosomal dominant or recessive [5,
6]. Patients usually present from childhood to early adult-
hood, with hematuria. Most male patients have near nor-
mal kidney function at birth that deteriorates over time,
leading to end-stage renal disease by the end of the third
decade [1–3]. The hallmark feature of the disorder is
multilaminar splitting of the glomerular basement mem-
brane (GBM), as shown by electron microscopy. The
molecular defects underlying Alport syndrome are muta-
tions in the genes for type IV collagen. How the gene
mutations alter the structure of type IV collagen are largely
unknown, as are the mechanisms underlying the progres-
sion of the nephropathy to end-stage renal disease.
Type IV collagen is a family of six distinct a(IV)-chains
[7]. These are designated a1 to a6, and are encoded by six
genes, COL4A1 to COL4A6. The GBM is comprised of
five of these chains, a1 to a5 [8, 9]. These five chains are
assembled in triple helical molecules comprised of three a
chains, that self assemble to form supramolecular networks.
Two distinct networks have recently been established at the
biochemical level, an a1/a2 network and an a3/a4/a5
network [10]. This novel a3/a4/a5 network is characterized
by loops and supercoiled triple helices that are stabilized by
disulfide bonds.
In the X-linked form of Alport syndrome, over 200
mutations have been found in the COL4A5 gene [11].
These mutations lead to the assembly of an adult GBM that
is abnormal with respect to morphology and composition of
type IV collagen chains. In contrast to normal GBM,
Alport GBM is comprised of only a1 and a2 chains, and is
devoid of the a3, a4, and a5 chains of type IV collagen [8,
9, 12, 13]. The altered chain composition appears to reflect
an arrest of an early developmental switch, wherein the
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fetal a1 and a2 chains persist in adult GBM and are not
replaced by the a3, a4, and a5 chains [14]. This switch can
now be defined at the supramolecular level in which the
fetal a1/a2 network is replaced by the a3/a4/a5 network in
normal glomerular development [10], but in Alport syn-
drome the switch is arrested. The newly described a3/a4/a5
network provides a plausible explanation for the absence of
the a5 chain as well as the a3 and a4 chains in Alport
syndrome, wherein the a5 chain is required for the assem-
bly of the a3 and a4 chains in the network [10, 15].
Although renal function is near normal in Alport pa-
tients at birth, it is unknown whether glomerular develop-
ment and GBM morphology are normal at that time.
Subsequent postnatal events such as proteolysis are pre-
sumed to cause progressive deterioration of the GBM and
renal function owing to the absence of the a3/a4/a5
network [14]. Since patients with Alport syndrome are for
practical purposes biopsied only when they develop disease,
glomerular development and presymptomatic GBM mor-
phology cannot be studied in these patients.
To circumvent this limitation, we utilized the Samoyed
dog model of X-linked hereditary nephritis in the present
study to investigate the timing and the role of the a1/a2 and
a3/a4/a5 networks in glomerular development and main-
tenance of glomerular function. This model results from a
nonsense mutation in the COL4A5 gene [16] and closely
mimics human Alport syndrome at the clinical, morpholog-
ical and immunohistochemical levels [17–20]. Our results
confirm the existence of a developmental switch for type IV
collagen networks and that the switch is arrested by the
COL4A5 gene mutation. The findings establish that only
the a1/a2 network is essential for normal glomerular
development, whereas the a3/a4/a5 network is essential for
long-term stability of the GBM and maintenance of glo-
merular function. Moreover, the findings reveal that GBM
deterioration in Alport syndrome is a postnatal process.
METHODS
Dogs used in this study were from the Samoyed heredi-
tary nephritis pedigree. For electron microscopy, samples
of renal cortex from six-day-old, three-week-old and one-
month-old dogs were fixed in a 4% paraformaldehyde-1%
glutaraldehyde mixture, post-fixed in osmium tetroxide,
and embedded in an Epon-Araldite mixture. Sections were
cut at 50 nm, stained with uranyl acetate and lead citrate
and viewed on a Philips 400 electron microscope. For
immunostaining, samples of renal cortex from six-day-old
and one-month-old dogs were embedded in OCT, snap-
frozen in liquid nitrogen and sectioned at 5 m. Frozen
sections were fixed in acetone and stained with antibodies
specific for each of the six a chains of collagen type IV. The
antibodies used were rat monoclonals raised against pep-
tide sequences specific for each of the a1-a6 chains of
collagen type IV. Their specificity and the reactive epitopes
(Table 1) have been previously established [9, 21]. These
antibodies were shown in a previous study to react with
a3-a5 chains of dog glomeruli by Western blot [20]. The
epitopes are given above with the comparable canine
sequence; the epitopes for the a6 chains have not yet been
mapped. Kidney sections were pretreated for 10 minutes
with an acid-KCl solution (pH 1.5) to expose epitopes and
then blocked with 1.5% normal rabbit serum (Sigma, St.
Louis, MO, USA). An ABC immunoperoxidase technique
was used: the primary antibody (1:100 dilution for 1.5 hr)
was followed by a biotinylated rabbit anti-rat antibody
(1:200 dilution for 1 hr; Vector Laboratories, Burlingame,
CA, USA), then a peroxidase-conjugated avidin-biotin
complex for 30 minutes (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), with a five minute incubation in diami-
nobenzidine as a chromagen. Sections were then counter-
stained with hematoxylin.
For double immunostaining, sections of normal and
affected dog kidney were prepared as above. The rat
monoclonal anti-a3 antibody was applied followed by an
FITC-conjugated goat-anti rat antibody (1:30 dilution for 1
hr; Organon Teknika, West Chester, PA, USA). Following
this, a mouse anti-collagen type IV antibody (Dako,
Glostrup, Denmark) was applied (1:10 dilution for 1 hr)
followed by a rhodamine conjugated goat anti-mouse anti-
body (1:30 dilution for 1 hr; Jackson Immunoresearch,
West Grove, PA, USA). The mouse anti-collagen type IV
antibody is a monoclonal raised against collagen type IV
peptides isolated from placenta, and shows identical reac-
tivity in tissue sections to the rat monoclonal anti-a1 and
anti-a2 antibodies.
RESULTS
Neonatal dog glomeruli
At six days of age, glomeruli could be distinguished at
different stages of development. Three different stages
were evaluated: the pre-capillary stage (at six days of age,
these glomeruli are largely in the S phase); the early
capillary loop stage (when capillary loops are first seen in a
simplified vascular tuft) and the late capillary loop stage
(when the more complex vascular tuft of a mature glomer-
ulus is present). No histologic differences were apparent at
Table 1. Specificity and reactive epitopes of the monoclonal antibodies
for each of the a1–a6 chains of collagen type IV
Collagen
chain Epitope Source Canine sequence
Amino acid
match
a1 KKPTPSTL Human KKPTPSTL 8/8
a2 DTLKAGLIR Human DTLKAGL??? 6/6?
a3 IPSTVKA Human IPSTTKA 6/7
a4 PAPDTLKE Human PSPDTLKE 7/8
a4 FSSAP Human FSSAP 5/5
a5 SKPQSETL Human SKPQSETL 8/8
a5 IDVEF Human IDVEF 5/5
a6 ? Murine
a6 ? Bovine
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the light microscopic level between normal and affected
dogs.
Ultrastructural appearance of the glomerular basement
membrane
No differences were apparent between normal and af-
fected dogs until one month of age (see Fig. 1). In the
neonatal period, immature glomeruli showed a bilaminar
appearance to the GBM with separate endothelial and
epithelial basement membranes separated by an electron
lucent region (Fig. 1A). In the more mature glomeruli,
these two basement membranes became apposed into a
single GBM with the classic trilaminar appearance of
lamina dense bordered on both the endothelial and epithe-
lial sides by a lamina rara (Fig. 1B). This appearance
persisted in both normal and affected dogs (Fig. 1C) until
one month of age, at which time foci of bilaminar ‘splitting’
became apparent in affected dog GBM (Fig. 1D), while the
appearance of the normal dog GBM remained unchanged
(result not shown).
The a1 and a2 chains of collagen type IV
In normal dogs, the staining distribution for the a1 and
a2 chains of collagen type IV was identical (Table 2 and
Figs. 2 A-C and 3 A-C). The pre-capillary stage (Figs. 2A
and 3A) showed positive staining around the epithelial
component destined to become Bowman’s epithelium and
podocytes. The ingrowing mesenchymal component des-
tined to become endothelial and mesangial cells was also
positive. The early capillary loop stage (Figs. 2B and 3B)
showed positive staining of capillary loops, mesangial re-
gions and Bowman’s capsule. In the late capillary loop
stage (Figs. 2C and 3C), the mesangial region and Bow-
man’s capsule remained positive, while the staining of
capillary loops diminished. Staining for the a1 and a2
chains of collagen type IV in affected dog glomeruli was
similar to normal dogs with some notable differences (Figs.
2 D-F and 3 D-F). The pre-capillary (2 days and 3 days) and
early capillary loop (Figs. 2E and 3E) stages were identical
to those in normal dog. In the late capillary loop stage
(Figs. 2F and 3F), however, the capillary loops remained
positive along with the mesangial region and Bowman’s
capsule.
The a3 and a4 chains of collagen type IV
In normal dogs, the pattern of staining for the a3 and a4
chains of collagen type IV was identical (Table 2 and Figs.
Fig. 1. Ultrastructural appearance of the
glomerular basement membrane (GBM). At six
days of age, immature glomeruli (A) show a
bilaminar GBM with distinct endothelial and
epithelial basement membranes separated by an
electron lucent region. In the more mature
glomeruli (B), these two basement membranes
become apposed into a single GBM with the
classic trilaminar appearance. This appearance
persists in both normal and affected dogs up to
three weeks of age (C). Only by one month can
affected dogs be distinguished, at which time
foci of bilaminar ‘splitting’ became apparent in
GBM (D), while the appearance of the normal
dog GBM remains normal (result not shown).
Table 2. Stage and location of staining
Status Stage Component a1 a2 a3 a4 a5 a6
Normal Pre-cap 1 1 2 2 2/1 2/1
Early GBM 1 1 1 1 1 2
Mesangium 1 1 2 2 2 2
Bowman’s C 1 1 2 2 1 1
Late GBM 6 6 1 1 1 2
Messangium 1 1 2 2 2 2
Bowman’s C 1 1 2 2 1 1
Affected Pre-cap 1 1 2 2 2 2
Early GBM 1 1 2 2 2 2
Mesangium 1 1 2 2 2 2
Bowman’s C 1 1 2 2 2 2
Late GBM 1 1 2 2 2 2
Mesangium 1 1 2 2 2 2
Bowman’s C 1 1 2 2 2 2
Symbols are: 1, positive; 2, negative; 6, weakly positive; 2/1, some
negative and some positive.
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4 A-C and 5 A-C). The pre-capillary stage (Figs. 4A and
5A) showed no staining for either chain. The early capillary
loop stage (Figs. 4B and 5B) showed positive staining of
capillary loops only, with mesangial regions and Bowman’s
capsule negative. In the late capillary loop stage (Figs. 4C
and 5C), this pattern of staining persisted. In the case of
affected dog glomeruli, there is no staining of any basement
membrane at any stage for both the a3 and a4 chains (Figs.
4 D-F and 5 D-F). However, in the late capillary loop stage
(Fig. 4F and 5F), there is positive staining of podocytes for
the a3 chain but not the a4 chain.
The a5 chain of collagen type IV
In normal dog glomeruli (Table 2 and Fig. 6 A-D), two
different patterns of staining were observed in the pre-
capillary stage. A minority showed no staining of any
basement membrane (Fig. 6A), while the majority showed
staining for the a5 chain around the epithelial component
destined to become Bowman’s epithelium and podocytes
(Fig. 6B). The ingrowing mesenchymal component re-
mained negative. At the early capillary loop stage (Fig. 6C),
there was positive staining of capillary loops and Bowman’s
Figs. 2 and 3. Staining for the a1 chain (Fig.
2) and a2 chain (Fig. 3) of collagen type IV in
normal (A-C) and affected (D-F) dog glomeruli.
In normal dogs, the pre-capillary stage (A)
shows positive staining around the epithelial
component destined to become Bowman’s
epithelium and podocytes. The ingrowing
mesenchymal component destined to become
endothelial and mesangial cells is also positive.
The immature GBM stage (B) shows positive
staining of capillary loops, mesangial regions
and around Bowman’s capsule. In the mature
GBM stage (C), the mesangial region and
Bowman’s capsule remain positive, while the
staining of capillary loops diminishes. In
affected dog glomeruli the pre-capillary (D)
and immature GBM (E) stages are identical to
those in normal dog. In the mature GBM stage
(F), however, the capillary loops remain
positive along with the mesangial region and
Bowman’s capsule.
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capsule, while mesangial regions was negative. This pattern
of staining persists in the late capillary loop stage (Fig. 6D).
There was no staining of any basement membrane at any
stage in affected dog glomeruli (Fig. 6 E-G).
The a6 chain of collagen type IV
In normal dog glomeruli (Table 2 and Fig. 7 A-D), again
two different patterns of staining could be observed in the
pre-capillary stage. Some glomeruli showed no staining for
the a6 chain (Fig. 7A), while in others there was staining
around the epithelial component destined to become Bow-
man’s epithelium and podocytes (Fig. 7B). The ingrowing
mesenchymal component was consistently negative. At the
early capillary loop stage (Fig. 7C), there was positive
staining limited to Bowman’s capsule. In the late capillary
loop stage (Fig. 7D), staining for the a6 chain remained
limited to Bowman’s capsule. In affected dog glomeruli, no
Figs. 4 and 5. Staining for the a3 chain (Fig.
4) and a4 chain (Fig. 5) of collagen type IV in
normal (A-C) and affected (D-F) dog glomeruli.
In normal dogs, the pre-capillary stage (A)
shows no staining. The immature GBM stage
(B) shows positive staining of capillary loops
only, while mesangial regions and Bowman’s
capsule are negative. In the mature GBM stage
(C), this pattern of staining persists. In affected
dog glomeruli, there is no staining of any
basement membrane at the pre-capillary (D),
immature GBM (E) or mature GBM (F)
stages. In the mature GBM stage, however,
there is positive cytoplasmic staining of
podocytes for the a3 chain.
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staining of any basement membrane was detected at any
stage (Fig. 7 E-G).
Double immunostaining for the a1 and a3 chains
This was performed to establish that the localization of
the a3 chain with respect to the GBM in normal and
affected dogs (Fig. 8). The results of this procedure con-
firmed, within the same glomerulus, the results described
above for the a1 chain and a3 chains separately, in both
normal and affected dog kidney.
One-month-old dogs
Immunostaining results for the a1-a6 chains were essen-
tially the same at those seen in the mature glomeruli of
neonatal dogs (results not shown). In normal dog glomer-
uli, the mesangial matrix contained the a1 and a2 chains,
Fig. 6. Staining for the a5 chain of collagen
type IV in normal (A-D) and affected (E-G) dog
glomeruli. The early pre-capillary stage (A)
shows no staining, but later in this stage (B)
there is staining around the epithelial
component destined to become Bowman’s
epithelium and podocytes. The ingrowing
mesenchymal component is negative. The
immature GBM stage (C) shows positive
staining of capillary loops and Bowman’s
capsule, while mesangial regions are negative.
In the mature GBM stage (D), this pattern of
staining persists. In affected dog glomeruli,
there is no staining of any basement membrane
at any of the pre-capillary (E), immature GBM
(F) and mature GBM (G) stages.
Fig. 7. Staining for the a6 chain of collagen
type IV in normal (A-D) and affected (E-G) dog
glomeruli. The early pre-capillary stage (A)
shows no staining, but later in this stage (B)
there is staining around the epithelial
component destined to become Bowman’s
epithelium and podocytes. The ingrowing
mesenchymal component is negative. The
immature GBM stage (C) shows positive
staining limited to Bowman’s capsule. In the
mature GBM stage (D), this pattern of staining
persists. In affected dog glomeruli, there is no
staining of any basement membrane at any of
the pre-capillary (E), immature GBM (F) and
mature GBM (G) stages.
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while the GBM contained mainly the a3-a5 chains, with
weak staining for the a1 and a2 chains. Bowman’s capsule
contained the a1, a2, a5 and a6 chains. In affected dog
glomeruli, there was positive staining only for the a1 and
a2 chains in the mesangial matrix, GBM and Bowman’s
capsule. Staining for the a3 chain was just barely detectable
in podocytes of affected male dogs, representing a reduc-
tion from that noted in the neonatal affected dogs.
DISCUSSION
Our studies in normal dogs have shown that as soon as
capillary loops are present in glomeruli, there is positive
staining of GBM for the a3-a5 chains of collagen type IV.
Prior to this stage, the a1 and a2 chains are the predomi-
nant chains present, although the a5 and a6 chains begin to
appear in Bowman’s capsule. The formation of capillary
loops corresponds to the appearance of GBM distinct from
mesangial matrix. As glomeruli mature, the a1 and a2
chains tend to disappear from the GBM, while the a3, a4
and a5 chains remain, implying there is active remodeling
of the GBM during glomerular development. This involves
the turning on of the genes producing the a3-a5 chains,
which can be termed a ’developmental switch’ changing a
’fetal’ GBM to an ’adult’ GBM. In developing dog glomer-
uli, production of the a5 chain precedes the a3 and a4
chains. The idea that GBM collagens might undergo a
developmental switch was first suggested in rodents [22], in
which developing glomeruli go through a similar sequence
of changes in collagen type IV chains as we have observed
in the dog, including the a5 chain appearing before the a3
and a4 chains. Since that initial observation, this switch has
been described in human fetal glomeruli [14] and rat testis
[23].
The molecular basis for the switch is unknown, but must
involve a mechanism to link the expression and incorpora-
tion of the a3, a4 and a5 chains into a network because
mutations in the COL4A5 gene cause disruption of the
assembly of the a3 and a4 chains, as well as the a5 chain.
This latter finding was first demonstrated by immunohisto-
chemistry [8, 9, 12, 13] and later by biochemical analysis
[14]. These observations suggested that the a3, a4, and a5
chains might comprise a distinct network separate from the
classical network of a1 and a2 chains [12]. This hypothesis
has now been recently confirmed by studying both seminif-
erous tubule basement membrane and glomerular base-
ment membrane [10, 15] in which networks containing the
a3, a4, and a5 chains could be separated from the classic
a1- and a2-containing network. These findings established,
to our knowledge for the first time, a structural linkage
between the a3, a4 and a5 chains.
The developmental switch mechanism could operate at
the protein, mRNA and/or the gene levels. At the protein
level, events at both triple helix formation and supramo-
lecular assembly need to be considered. Should the a3, a4,
and a5 chains form heterotrimers, then an abnormal a5
chain could lead to faulty heterotrimer assembly resulting
in absence of these chains in Alport GBM. Should the a3
and a4 chains be in trimers distinct from those containing
the a5 chain, then the a5 chain may be necessary for
incorporation of a3- and a4-chain containing trimers.
Hence, an abnormality of a5-containing trimers could lead
to absence of the a3- and a4-containing trimers from
GBM. At the translational/transcriptional level, should the
expression of the a3, a4, or a5 chains be coordinated, then
in X-linked Alport syndrome the transcription or transla-
tion of the a3 and a4 chains might be impaired secondary
Fig. 8. Double immunostaining for the a1
chain (a and c) and a3 chain (b and d) of
collagen type IV in normal (a and b) and
affected (c and d) dog glomeruli. In normal
dogs, the a1 chain localizes to the mesangial
region and Bowman’s capsule, with weak
staining of capillary loops (a). The same
glomerulus shows linear staining of capillary
loops for the a3 chain, with no staining of the
mesangial region or Bowman’s capsule (b). In
affected dog glomeruli, the capillary loops are
positive for the a1 chain as well as the
mesangial region and Bowman’s capsule (c). In
contrast, staining for the a3 chain in the same
glomerulus is seen within podocyte cytoplasm
and not along any of the capillary loops (d).
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to a mutation in the a5 gene. Evidence that the mechanism
of the switch affects the gene expression level comes from
our study of the expression of the a(IV) chains in the
kidney in canine X-linked nephritis [20]. The canine ne-
phritis is caused by a nonsense mutation in the COL4A5
gene that results in a $ 77% reduction of mRNA levels for
not only the a5 chain but also the a3 and a4 chains.
Additional support for this concept comes from the finding
that expression of the COL4A5 gene precedes that of the
COL4A3 and COL4A4 genes in developing rat kidney [22],
rat testis [23], murine kidney [24] and, in this paper,
developing dog kidney. Furthermore, in the COL4A3
knockout mouse model, loss of expression of the COL4A3
does not reduce the level of expression of the COL4A5
gene [25].
The protein assembly and the translational/transcrip-
tional mechanisms need not be mutually exclusive in that
the incorporation of the a5 chain into the extracellular
matrix could be required to modulate the transcription of
the a3 and a4 chains. This idea would be consistent with
our observation that the a5 chain appears earlier in canine
glomerular development than the a3 and a4 chains. A
novel observation in our studies was that podocytes of
affected dogs showed cytoplasmic staining for the a3 chain,
instead of in the GBM. Similar staining was not seen in
normal dogs. This result suggests an inability to export the
a3 chain into the extracellular matrix in the absence of the
a4 and/or a5 chains. Since collagen chains are only ex-
ported after formation of a triple helix [reviewed in 26], this
observation would imply the a3 chain is contained within
the same triple helix as the a4 and/or a5 chain, instead of
existing as an a3 homotrimer. The cytoplasmic staining for
the a3 chain is also detectable in affected dogs at one
month of age but not at four months, which could reflect a
down-regulation of a3 chain production with time. In
support of this hypothesis, we have shown the mRNA level
for the a3 chain is reduced $ 77% at four months of age
[20].
In affected male dogs, only the a1 and a2 chains are
detected in GBM, and this pattern of staining persists in the
most mature glomeruli. The a3-a6 chains are not detected
in any basement membrane in the kidney. These results
corroborate at the immunohistochemical level our earlier
observations by Western blotting [20]. In other words, in
affected male dogs, there is persistence of an fetal collagen
network composed only of a1 and a2 chains. This can be
seen as a failure of the developmental switch mentioned
above, secondary to a COL4A5 mutation. Increased stain-
ing of the GBM in Alport syndrome for the a1 and a2
chains had been noted before [27]. This observation was
later incorporated into a hypothesis that there was a failure
of a developmental switch in Alport syndrome, based on
work with normal fetal kidney [14]. This could not be
confirmed experimentally since renal tissue from develop-
ing human glomeruli in Alport syndrome is not available.
Our canine model has provided the opportunity to explore
and confirm this hypothesis.
Despite this failure of the developmental switch, and the
resulting absence of the a3/a4/a5 network in GBM, the
affected dog GBM has a normal appearance by electron
microscopy up to one month of age as noted in earlier work
[17] and reaffirmed in the present study. Furthermore,
affected dogs do not develop proteinuria (the presenting
sign of their disease) until about two months of age [19].
Similarly, the COL4A3 knockout mice, which also lack the
a3/a4/a5 network in their GBM, do not develop protein-
uria until two to three months of age [25]. These results are
seemingly at variance with the earlier observation that
progressive replacement of the a1 and a2 chains in the rat
GBM by the a3 chain was associated with acquisition of
permselectivity [28]. Instead, it would appear from our
results that an a1/a2 network is capable of forming a
morphologically normal GBM (as assessed at the EM
level), which confers normal renal function for a limited
period of time. This implies that only the a1/a2 network is
essential for normal glomerular development whereas the
a3/a4/a5 network is essential for the long-term stability of
the GBM and maintenance of glomerular function.
A plausible hypothesis is that the a3/a4/a5 network
confers long-term stability to GBM by protecting against
proteolytic degradation [14]. The a3 and a4 chains are
more cysteine rich in their 7S and triple helical regions than
the a1 and a2 chains leading to a loop structure of the
triple-helix covalently crosslinked by disulfide bonds. In this
regard, the a1/a2 network is more easily extracted by
pseudolysin than the a3/a4/a5 network [10, 15]. It has been
shown that glomerular epithelial and mesangial cells pro-
duce enzymes such as metalloproteinases, neutral protease,
and cathepsins that are capable of degrading basement
membrane components [29–32]. Recent work identified a
differential sensitivity of normal and Alport renal basement
membrane to endopeptidase degradation [14]. Alport base-
ment membrane was more readily degraded by bacterial
collagenase, pseudolysin, and cathepsin B and G compared
to control renal basement membranes. Additionally, the
normal NC1 hexamer of type IV collagen had a greater
resistance to proteolysis than the hexamer from Alport
kidney.
Overall our results, in conjunction with the work of
others, allow us formulate the following hypothesis (pre-
sented in diagram form in Fig. 9). Progression to end-stage
renal disease in X-linked Alport syndrome evolves from a
congenital malformation of the GBM, which alone is
insufficient to cause disease, but which is permissive to one
or more postnatal processes that deteriorate the GBM,
causing glomerular dysfunction. Specifically, the congenital
malformation of the GBM involves COL4A5 mutations
that arrest a developmental switch from the fetal a1/a2
network to the adult a3/a4/a5 network, and the persistence
of this fetal network predisposes the GBM to proteolytic
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degradation. The canine model of X-linked Alport syn-
drome will provide us with a unique opportunity to inves-
tigate this hypothesis and to pursue the mechanism of the
progression of the GBM abnormality in this disease.
Finally, there are implications of this work with respect
to using gene therapy to treat Alport syndrome. Since an
a1/a2 network is capable of forming a GBM that maintains
normal renal function for a limited period of time, this
provides a ‘time window’ during which one could adminis-
ter gene therapy before GBM damage begins. Although the
duration of this window of time in humans remains to be
determined, in utero gene therapy should not be necessary
for the treatment of Alport syndrome.
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